Anti-Cell Antibodies in Exposed Seronegative Individuals with HIV Type 1-Neutralizing Activity

No abstract is available for this paper.

• Publication year

  2000

• Venue

  AIDS Research and Human Retroviruses

• Publication date

  2000-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/088922200309458PMID 10659050
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Postattachment Neutralization of a Primary Strain of HIV Type 1 in Peripheral Blood Mononuclear Cells Is Mediated by CD4-Specific Antibodies But Not by a Glycoprotein 120-Specific Antibody that Gives Potent Standard Neutralization

  2001cited by this paper
• Evidence as a HIV-1 self-defense vaccine of cyclic chimeric dodecapeptide warped from undecapeptidyl arch of extracellular loop 2 in both CCR5 and CXCR4.

  2001cited by this paper
• Quantification of in vivo replicative capacity of HIV-1 in different compartments of infected cells.

  2001cited by this paper
• Human immunodeficiency virus (HIV)-specific IgA and HIV neutralizing activity in the serum of exposed seronegative partners of HIV-seropositive persons.

  1999cited by this paper
• Anti-CD4 Antibodies in Exposed Seronegative Adults and in Newborns of HIV Type 1-Seropositive Mothers: A Follow-up Study

  1999cited by this paper
• HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene.

  1998cited by this paper
• A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation

  1998cited by this paper
• Neutralizing antiviral B cell responses.

  1997cited by this paper
• HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals

  1997cited by this paper
• Chemokine receptors and HIV-1: an attractive pair?

  1996cited by this paper
• HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

  1996cited by this paper
• Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

  1996influential reference
• Human immunodeficiency virus type 1 (HIV-1)-seronegative injection drug users at risk for HIV exposure have antibodies to HLA class I antigens and T cells specific for HIV envelope.

  1996cited by this paper
• Relative resistance to HIV–1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high–risk sexual exposures

  1996cited by this paper
• Chemokine Receptors and HIV-1: Minireview An Attractive Pair?

  1996cited by this paper
• Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection.

  1996cited by this paper
• Autoantibodies to CD4 in HIV Type 1-Exposed Seronegative Individuals

  1996cited by this paper
• Protective immunity against HIV infection: has nature done the experiment for us?

  1996cited by this paper
• Role of HLA Class I in HIV Type 1-Induced Syncytium Formation

  1996cited by this paper
• Distinctive features of the alpha 1-domain alpha helix of HLA-C heavy chains free of beta 2-microglobulin.

  1996cited by this paper
• Studies in subjects with long-term nonprogressive human immunodeficiency virus infection.

  1995cited by this paper
• HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women

  1995cited by this paper
• Immune responses in HIV-exposed seronegatives: have they repelled the virus?

  1995cited by this paper
• Immunization with class I human histocompatibility leukocyte antigen can protect macaques against challenge infection with SIVmac‐32H

  1995cited by this paper
• Frequencies of opportunistic diseases prior to death among HIV‐infected persons

  1995cited by this paper
• A Resting Cell Assay for Improved Detection of Antibody-Mediated Neutralization of HIV Type 1 Primary Isolates

  1995cited by this paper
• Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients.

  1994cited by this paper
• HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood.

  1994cited by this paper
• TRANSIENT SEROREVERSION IN CHILDREN BORN TO HUMAN IMMUNODEFICIENCY VIRUS 1-INFECTED MOTHERS

  1994cited by this paper
• Autoantibodies against beta 2-microglobulin-free HLA antigens in AIDS patients.

  1993cited by this paper
• Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus‐1‐infected mothers

  1992cited by this paper
• Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1.

  1992cited by this paper
• The ability of certain SIV vaccines to provoke reactions against normal cells.

  1992cited by this paper
• Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates

  1992cited by this paper
• Anti-cell antibody in macaques

  1991cited by this paper
• Exposure to Human Immunodeficiency Virus Type I-Specific T Helper Cell Responses before Detection of Infection by Polymerase Chain Reaction and Serum Antibodies

  1991cited by this paper
• Exposure to human immunodeficiency virus (HIV) type I indicated by HIV-specific T helper cell responses before detection of infection by polymerase chain reaction and serum antibodies [corrected].

  1991cited by this paper
• Monoclonal Antibodies for Analysis of the HLA System

  1979cited by this paper

• Excess BAFF May Impact HIV-1-Specific Antibodies and May Promote Polyclonal Responses Including Those from First-Line Marginal Zone B-Cell Populations

  2023cites this paper
• Resistencia natural a la infección por el VIH-1. Revisión sistemática de la literatura

  2023cites this paper
• Alloimmunity to Class 2 Human Leucocyte Antigens May Reduce HIV-1 Acquisition – A Nested Case-Control Study in HIV-1 Serodiscordant Couples

  2022cites this paper
• Decreased Plasma Calcitonin Gene-Related Peptide as a Novel Biomarker for HIV-1 Disease Progression

  2021cites this paper
• Short Communication: Decreased Plasma Calcitonin Gene-Related Peptide as a Novel Biomarker for HIV-1 Disease Progression.

  2019cites this paper
• A high mucosal blocking score is associated with HIV protection

  2019cites this paper
• LUANDA MARA DA SILVA OLIVEIRA Avaliação fenotípica das células T CD4+ reguladoras, Th17, Th22 e Tc22 nos indivíduos expostos não infectados por HIV-1

  2016cites this paper
• An HIV gp120-CD4 Immunogen Does Not Elicit Autoimmune Antibody Responses in Cynomolgus Macaques

  2016cites this paper
• Mucosal Correlates of Protection in HIV‐1‐Exposed Sero‐negative Persons

  2014cites this paper
• Non Progressors: a possible protective effect against disease progression Long lasting CCR5 internalization by antibodies in a subset of Long Term

  2013cites this paper
• HIV exposed seronegative individuals show antibodies specifically recognizing native HIV envelope glycoprotein

  2013cites this paper
• Multi-faceted role of naturally occurring autoantibodies in fighting pathogens.

  2012cites this paper
• Host factors involved in low susceptibility to HIV infection.

  2011cites this paper
• HIV target cells and innate immune factors in the human female genital tract

  2011cites this paper
• FATTORI UMORALI PROTETTIVI COME STRUMENTI PER LA GENERAZIONE DI VACCINI EFFICACI CONTRO L'INFEZIONE DA HIV

  2011cites this paper
• Is Autoimmunity to CCR5 an Escape from the Intrusive HIV

  2010cites this paper
• CCR5: From Natural Resistance to a New Anti-HIV Strategy

  2010cites this paper
• Subtle Mimicry of HLA by HIV-1 GP120 – A Role for Anti HLA Antibodies?

  2010cites this paper
• The ‘immunologic advantage’ of HIV-exposed seronegative individuals

  2009cites this paper
• Mucosal and systemic immune responses in HIV-1 exposed uninfected individuals

  2009cites this paper
• Patologia específica de la salut reproductiva de la dona infectada pel virus de la immunodeficiència humana adquirida: de la concepció al part

  2009cites this paper
• The 'immunologic advantage' of HIV-exposed seronegative individuals

  2009cites this paper
• Excretion of Human Immunodeficiency Virus Type 1 through Polarized Epithelium by Immunoglobulin A

  2008cites this paper
• Use of the regulatory protein Nef for vaccination against HIV-1

  2008cites this paper
• Serodeconversion of HIV Antibody-Positive AIDS Patients Following Treatment with V-1 Immunitor

  2008cites this paper
• IGA MEDIATED DEFENSES AGAINST HIV-1

  2008cites this paper
• HLA-C increases HIV-1 infectivity and is associated with gp120

  2008cites this paper
• Inhibition of HIV‐1 entry by antibodies: potential viral and cellular targets

  2007cites this paper
• Quantitation of HLA Proteins Incorporated by Human Immunodeficiency Virus Type 1 and Assessment of Neutralizing Activity of Anti-HLA Antibodies

  2007cites this paper
• Neutralizing antibodies in mucosal secretions: IgG or IgA?

  2007cites this paper
• Detection of very early antibody to native HIV antigens by HIV neutralization and live-cell immunofluorescence assays.

  2006cites this paper
• Is autoimmunity a component of natural immunity to HIV?

  2006cites this paper
• Suppressed cellular alloimmune responses in HIV‐exposed seronegative female sex workers

  2006cites this paper
• Long-lasting CCR5 internalization by antibodies in a subset of long-term nonprogressors: a possible protective effect against disease progression.

  2006cites this paper
• Greater risk for HIV infection of black men who have sex with men: a critical literature review.

  2006cites this paper
• HIV-Specific Antibodies But Not T-Cell Responses Are Associated With Protection in Seronegative Partners of HIV-1-Infected Individuals in Cambodia

  2006cites this paper
• Therapeutic AIDS vaccines.

  2006cites this paper
• Innate and Adaptive Mucosal Immunity in Protection against HIV Infection

  2006cites this paper
• Predictive value of anti-cell and anti-human immunodeficiency virus (HIV) humoral responses in HIV-1-exposed seronegative cohorts of European and Asian origin.

  2005influential citation
• Global human genetics of HIV-1 infection and China

  2005cites this paper
• Humoral immunity in HIV-1 exposure: cause or effect of HIV resistance?

  2004cites this paper
• Oral Immunization with Recombinant Listeria monocytogenes Controls Virus Load after Vaginal Challenge with Feline Immunodeficiency Virus

  2004cites this paper
• Dissociation of CD4(+) cell counts from viral load and association with immune complexes in HIV(+) hemophilia patients.

  2004cites this paper
• Correlates of protective immunity among HIV-exposed seronegative female sex workers in Abidjan, Côte d'Ivoire

  2003cites this paper
• Most highly exposed seronegative men lack HIV-1-specific, IFN-gamma-secreting T cells.

  2003cites this paper
• Most Highly Exposed Seronegative Men Lack HIV-1-Specific, IFN-γ-Secreting T Cells 1

  2003cites this paper
• Innate and adaptive mucosal immunity in protection against HIV infection.

  2003cites this paper
• Complement-Mediated Enhancement of HIV-1 Neutralisation by Anti-HLA Antibodies Derived from Polytransfused Patients

  2003cites this paper
• Mucosal AIDS Vaccines

  2003cites this paper
• Serum IgA of HIV-exposed uninfected individuals inhibit HIV through recognition of a region within the α-helix of gp41

  2002cites this paper
• Characterisation of HIV-specific Immunity in a Cohort of High-risk Kenyan Sex Workers

  2002cites this paper
• Synthetic AIDS vaccine by targeting HIV receptor.

  2002cites this paper
• Biological, epidemiological and clinical basis of understanding human immunodeficiency virus infection.

  2001cites this paper
• Evidence as a HIV-1 self-defense vaccine of cyclic chimeric dodecapeptide warped from undecapeptidyl arch of extracellular loop 2 in both CCR5 and CXCR4.

  2001cites this paper
• Postattachment Neutralization of a Primary Strain of HIV Type 1 in Peripheral Blood Mononuclear Cells Is Mediated by CD4-Specific Antibodies But Not by a Glycoprotein 120-Specific Antibody that Gives Potent Standard Neutralization

  2001cites this paper
• Quantification of in vivo replicative capacity of HIV-1 in different compartments of infected cells.

  2001cites this paper
• New insights into protective humoral responses and HIV vaccines.

  2001cites this paper
• Quantification of In Vivo Replicative Capacity of HIV‐1 in Different Compartments of Infected Cells

  2001cites this paper
• The mucosal immunity in HIV-1 exposed seronegative individuals and expression of HIV-1 gp160 protein in transgenic plants

  2001cites this paper
• Characterisation of Humoral Immune Responses to HIV-Non-Structural Proteins Nef

  2001cites this paper
• HIV-1 In Vitro Neutralize the Infectivity of R 5 Strains of Down-Modulate Surface CCR 5 In Vivo and Partners of HIV-Seropositive Individuals CCR 5-Reactive Antibodies in Seronegative

  2000cites this paper
• Down-Modulate Surface CCR5 In Vivo and Partners of HIV-Seropositive Individuals CCR5-Reactive Antibodies in Seronegative

  2000cites this paper
• CCR5-Reactive Antibodies in Seronegative Partners of HIV-Seropositive Individuals Down-Modulate Surface CCR5 In Vivo and Neutralize the Infectivity of R5 Strains of HIV-1 In Vitro1

  2000cites this paper
• Anti-CD4 Antibodies in Exposed Seronegative Adults and in Newborns of HIV Type 1-Seropositive Mothers: A Follow-up Study

  1999cites this paper